|

Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key

ByHolly Zink
Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key

Scientists believe that particles called extracellular vesicles could be used as biomarkers to identify malignant pleural mesothelioma (MPM).

Malignant pleural mesothelioma is an aggressive and deadly cancer that affects the lining of the lungs and chest cavity. It is caused by exposure to asbestos, usually at work. It has a low survival rate, so it is important to find ways to diagnose it early. It is also important for doctors to be able to predict how it will develop in patients.

How Mesothelioma is Diagnosed

Mesothelioma is usually diagnosed after a person goes to a doctor because they are experiencing symptoms. For MPM, a person might feel shortness of breath due to fluid around the lung, chest pain, cough, and fatigue.

Doctors diagnose mesothelioma with a few different procedures. They might perform a scan on a patient first. This is usually an x-ray or a CT scan.

Once they find a potential cancer site, the doctor needs to remove part of the tissue to take a closer look. The doctor will perform a biopsy to get the sample. This usually involves an invasive surgery.

How Extracellular Vesicles Could be Used

Scientists in Australia are studying tiny particles called extracellular vesicles that are released by cancer cells. These particles are produced by both cancerous and healthy cells and help cells to communicate with each other. Extracellular vesicles could be used as biomarkers to help with diagnosis and treatment decisions.

To further explore this, the scientists analyzed different types of extracellular vesicles from malignant pleural mesothelioma cells and compared them to normal cells.

They discovered that each type of extracellular vesicle had different proteins inside them. Most importantly, the scientists found new proteins that are associated with malignant pleural mesothelioma, including mesothelin.

The scientists believe that analyzing proteins in extracellular vesicles could help to identify biomarkers for MPM from simple blood tests. These biomarkers may be able to help doctors reach a faster diagnosis, determine prognosis, and create effective treatment plans.

Source

Ahmadzada T, Vijayan A, Vafaee F, et al. Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential. Cancers (Basel). 2023;15(8):2364. Published 2023 Apr 18. doi:10.3390/cancers15082364. https://www.mdpi.com/2072-6694/15/8/2364

Similar Posts

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    ByAlex Strauss

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…